- Home
- YI vs BEAT Comparison
YI vs BEAT Comparison
Compare YI & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YI
- BEAT
- Stock Information
- Founded
- YI 2010
- BEAT 2015
- Country
- YI China
- BEAT United States
- Employees
- YI N/A
- BEAT 20
- Industry
- YI Retail-Drug Stores and Proprietary Stores
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- YI Consumer Staples
- BEAT Technology
- Exchange
- YI Nasdaq
- BEAT Nasdaq
- Market Cap
- YI 71.1M
- BEAT 74.1M
- IPO Year
- YI N/A
- BEAT 2021
- Fundamental
- Price
- YI $0.79
- BEAT $2.56
- Analyst Decision
- YI
- BEAT Buy
- Analyst Count
- YI 0
- BEAT 1
- Target Price
- YI N/A
- BEAT $8.00
- AVG Volume (30 Days)
- YI 182.3K
- BEAT 282.2K
- Earning Date
- YI 11-27-2024
- BEAT 11-07-2024
- Dividend Yield
- YI N/A
- BEAT N/A
- EPS Growth
- YI N/A
- BEAT N/A
- EPS
- YI N/A
- BEAT N/A
- Revenue
- YI $2,090,255,896.00
- BEAT N/A
- Revenue This Year
- YI $61.85
- BEAT N/A
- Revenue Next Year
- YI N/A
- BEAT N/A
- P/E Ratio
- YI N/A
- BEAT N/A
- Revenue Growth
- YI N/A
- BEAT N/A
- 52 Week Low
- YI $0.55
- BEAT $1.06
- 52 Week High
- YI $1.85
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- YI 52.81
- BEAT 47.14
- Support Level
- YI $0.75
- BEAT $2.28
- Resistance Level
- YI $0.85
- BEAT $3.48
- Average True Range (ATR)
- YI 0.06
- BEAT 0.29
- MACD
- YI 0.00
- BEAT -0.05
- Stochastic Oscillator
- YI 35.29
- BEAT 37.83
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.